A Study to Investigate the Effect of AZD0780 Tablets in Combination With Rosuvastatin Tablets on Low Density Lipoprotein Cholesterol Levels (LDL-C) in Adult Participants With Dyslipidaemia

NCT07218900 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

76

Enrollment

INDUSTRY

Sponsor class

Conditions

Dyslipidaemia

Interventions

DRUG: Placebo
DRUG: AZD0780
DRUG: Rosuvastatin

Sponsor

AstraZeneca